Healthcare Triangle, Inc. (HCTI) Income Statement
HCTI 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsHCTI revenue and net income
Where HCTI's revenue goes
2025Each bar shows an amount and its share of revenue. HCTI kept −68.2% of revenue as net income.
HCTI profit margins
HCTI growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +18.8% | −32.9% | −15.0% | +80.8% |
| Gross profit | −34.6% | −44.9% | −24.7% | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
HCTI quarterly EPS vs estimates
Healthcare Triangle beat the analyst EPS estimate in 1 of the last 5 quarters. Next report: November 12, 2026 (estimate $-0.97).
HCTI income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.9M | $11.7M | $33.2M | $45.9M | $35.3M | $31.3M | $28.7M | $232,359 | $5,815 | $29,370 |
| Cost of revenue | $12.0M | $8.8M | $26.4M | $34.6M | $24.7M | $23.6M | $23.7M | $134,325 | $4,610 | $1,994 |
| Gross profit | $1.9M | $2.9M | $6.8M | $11.3M | $10.5M | $7.8M | $5.1M | $98,034 | $1,205 | $27,376 |
| Research & development | $536,000 | $429,000 | $799,000 | $8.1M | $5.3M | $1.7M | $1.0M | $0 | $0 | $0 |
| Sales, general & admin | $10.4M | $6.2M | $10.4M | $12.2M | $9.2M | $4.9M | $2.4M | $1.1M | $1.9M | $2.9M |
| Total operating expenses | $11.7M | $7.6M | $14.5M | $27.6M | $15.9M | $6.6M | $3.4M | $1.5M | $3.0M | $3.8M |
| Operating income | −$9.8M | −$4.8M | −$7.7M | −$16.3M | −$5.4M | $1.2M | $1.7M | −$1.3M | −$3.0M | −$3.7M |
| Interest expense | $567,000 | $1.2M | $968,000 | $212,000 | $567,000 | $78,646 | $52,576 | $0 | $0 | $0 |
| Income before taxes | −$9.5M | −$6.0M | −$8.7M | −$13.9M | −$5.9M | $2.6M | $1.6M | −$4.6M | −$6.7M | −$5.8M |
| Income taxes | — | $12,000 | $35,000 | $506,000 | $24,000 | $257,381 | $444,371 | $0 | $0 | $0 |
| Net income | −$9.5M | −$6.0M | −$8.7M | −$14.4M | −$5.9M | $2.4M | $1.2M | −$4.6M | −$6.7M | −$5.8M |
| EBITDA | −$8.2M | −$3.9M | −$6.1M | −$10.7M | −$3.9M | $2.0M | $2.4M | — | — | — |
| EPS (diluted) | −$44.45 | −$126.27 | −$2.20 | −$20467.71 | −$0.07 | $210.13 | — | −$0.54 | −$230.85 | — |
| Gross margin | 13.6% | 24.7% | 20.4% | 24.6% | 29.8% | 24.8% | 17.7% | 42.2% | 20.7% | 93.2% |
| Operating margin | −70.5% | −40.6% | −23.2% | −35.6% | −15.2% | 3.8% | 5.8% | −554.5% | −51,186.3% | −12,696.5% |
| Net margin | −68.2% | −51.0% | −26.2% | −31.3% | −16.9% | 7.5% | 4.1% | −1,970.2% | −115,757.5% | −19,864.8% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.2M | $9.9M | $3.1M | $3.5M | $3.6M | $3.7M | $2.2M | $2.4M | $3.0M | $4.1M | $7.1M | $7.8M |
| Cost of revenue | $7.1M | $8.3M | $2.7M | $2.9M | $3.1M | $3.4M | $1.9M | $1.7M | $2.6M | $3.6M | $5.5M | $6.8M |
| Gross profit | $2.1M | $1.6M | $448,000 | $618,000 | $494,000 | $329,000 | $256,000 | $722,000 | $364,000 | $478,000 | $1.5M | $995,000 |
| Research & development | $51,000 | $85,000 | $279,000 | $59,000 | $55,000 | $144,000 | $80,000 | $175,000 | $207,000 | $127,000 | $104,000 | $54,000 |
| Sales, general & admin | $5.5M | $5.0M | $3.9M | $3.1M | $1.8M | $1.6M | $793,000 | $1.4M | $1.5M | $2.1M | $1.6M | $2.5M |
| Total operating expenses | $6.1M | $5.2M | $7.6M | $3.2M | $1.9M | $1.7M | $1.1M | $1.9M | $1.7M | $2.2M | $2.0M | $2.5M |
| Operating income | −$4.1M | −$3.6M | −$4.4M | −$2.6M | −$1.4M | −$1.4M | −$852,000 | −$1.2M | −$1.4M | −$1.7M | −$479,000 | −$1.5M |
| Interest expense | $89,000 | $85,000 | $100,000 | $32,000 | $21,000 | $413,000 | $853,000 | $80,000 | $131,000 | $149,000 | $305,000 | $415,000 |
| Income before taxes | −$4.4M | −$6.2M | −$4.5M | −$1.9M | −$1.4M | −$1.7M | −$1.3M | −$1.2M | −$1.5M | −$1.9M | −$1.7M | −$1.9M |
| Income taxes | $24,000 | — | — | — | — | — | $4,000 | $2,000 | $1,000 | $5,000 | $7,000 | $4,000 |
| Net income | −$4.4M | −$6.2M | −$4.5M | −$1.9M | −$1.4M | −$1.7M | −$1.3M | −$1.2M | −$1.5M | −$1.9M | −$1.7M | −$1.9M |
| EBITDA | −$3.8M | −$5.3M | −$3.8M | −$1.8M | −$1.3M | −$1.3M | −$491,000 | −$824,000 | −$844,000 | −$1.2M | −$1.4M | −$812,000 |
| EPS (diluted) | −$1.56 | −$18.50 | −$18.50 | −$25.20 | −$0.58 | −$0.17 | −$0.24 | −$54.89 | −$70.72 | −$0.42 | −$1.24 | −$0.46 |
| Gross margin | 22.5% | 16.1% | 14.3% | 17.7% | 13.9% | 8.9% | 11.7% | 29.9% | 12.2% | 11.6% | 21.7% | 12.8% |
| Operating margin | −44.3% | −36.8% | −141.0% | −74.3% | −38.2% | −37.7% | −38.9% | −48.4% | −46.2% | −41.6% | −6.8% | −19.6% |
| Net margin | −48.0% | −62.9% | −143.5% | −54.6% | −38.4% | −45.9% | −61.6% | −51.8% | −50.6% | −45.3% | −23.8% | −25.0% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in HCTI's financial statements (latest annual report filed April 15, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
HCTI financial results
In fiscal year 2025 (ended December 31, 2025), Healthcare Triangle reported revenue of $13.9 million, up 18.8% from the year before. It had a net loss of $9.5 million, a net profit margin of −68.2%. Diluted earnings per share came to −$44.45. Over five years revenue grew at an average rate of −15.0% a year.
See the HCTI stock overview for the latest quote and news, or the HCTI chart for price history and technical indicators.
HCTI income statement FAQ
What is Healthcare Triangle's annual revenue?
Healthcare Triangle reported total revenue of $13.9 million for fiscal year 2025, which ended on December 31, 2025. That was up 18.8% from $11.7 million the previous year.
Is Healthcare Triangle profitable?
No. Healthcare Triangle reported a net loss of $9.5 million in fiscal 2025, a net profit margin of −68.2%; its operating margin was −70.5%.
What is Healthcare Triangle's gross margin?
Healthcare Triangle's gross margin was 13.6% in fiscal 2025: for every $100 of revenue, Healthcare Triangle kept $14 after the direct cost of its products and services.
How much does Healthcare Triangle spend on research and development?
Healthcare Triangle spent $0.5 million on research and development in fiscal 2025, 3.9% of revenue.
How fast is Healthcare Triangle growing?
Revenue grew −15.0% a year on average over the last five fiscal years, from $31.3 million to $13.9 million.
What are Healthcare Triangle's earnings per share?
Healthcare Triangle earned $-44.45 per diluted share in fiscal 2025, compared with $-126.27 a year earlier.
When will Healthcare Triangle report its next earnings?
Healthcare Triangle is expected to report results for the quarter ending September 30, 2026 on November 12, 2026.
When does Healthcare Triangle's fiscal year end?
Healthcare Triangle's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on April 15, 2026.